Blogroll

Minerva's schizophrenia drug misses main goal in study; shares tumble

Health News (Reuters) - Fri, 05/29/2020 - 14:58
Drug developer Minerva Neurosciences Inc said on Friday its experimental drug for schizophrenia did not meet the main goal of a late-stage study, sending its shares down nearly 66% in early trade.
Categories: Health

Little fear, lots of love as Madrid medics do home rounds amid pandemic

Health News (Reuters) - Fri, 05/29/2020 - 14:47
With air kisses and palms clasped, elderly patients in Madrid greet medics who come to check them at home during the coronavirus pandemic despite the risks involved.
Categories: Health

German regulator examines stock trades by Wirecard CEO

Technology News (Reuters) - Fri, 05/29/2020 - 14:45
Germany's market regulator said on Friday it was investigating whether Markus Braun, the CEO of payments firm Wirecard, had violated insider-trading rules by buying stock during the quiet period before publication of its annual report.
Categories: Technology

J&J's Ebola vaccine wins EU regulatory panel backing

Health News (Reuters) - Fri, 05/29/2020 - 14:37
A panel of the European health regulator on Friday recommended approving Johnson & Johnson's two-dose experimental vaccine for Ebola in the European Union.
Categories: Health

Uber launches hourly ride booking option in some U.S. cities

Technology News (Reuters) - Fri, 05/29/2020 - 14:07
Uber Technologies Inc on Friday said it would offer rides by the hour in some U.S. cities, a feature aimed at helping Americans with essential trips during the coronavirus pandemic.
Categories: Technology

Britain seeking new entrants to 5G market: PM's spokesman

Technology News (Reuters) - Fri, 05/29/2020 - 13:24
Britain set out in January that it was seeking entrants into the market for 5G telecommunications and that London is speaking to allies about it such as the United States, a spokesman for Prime Minister Boris Johnson said on Friday.
Categories: Technology

AstraZeneca, Daiichi niche drug shows promise beyond breast cancer

Health News (Reuters) - Fri, 05/29/2020 - 13:08
AstraZeneca and Daiichi Sankyo's Enhertu helped patients with three different types of cancer live longer in trials, pointing to potential broader use of the breast cancer treatment.
Categories: Health

What you need to know about the coronavirus right now

Health News (Reuters) - Fri, 05/29/2020 - 12:44
Here's what you need to know about the coronavirus right now:
Categories: Health

EU regulator promises speedy review of potential COVID-19 drug remdesivir

Health News (Reuters) - Fri, 05/29/2020 - 12:38
The European health regulator has vowed to conduct a speedy review of Gilead Sciences' potential COVID-19 drug, remdesivir, but said it has not yet received an application from the U.S. drugmaker.
Categories: Health

Pakistan drug firm to import potential COVID-19 treatment from Bangladesh

Health News (Reuters) - Fri, 05/29/2020 - 12:15
A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, it said in a stock exchange filing on Friday.
Categories: Health

China reports African swine fever outbreak in Gansu province

Health News (Reuters) - Fri, 05/29/2020 - 12:06
China's Ministry of Agriculture and Rural Affairs said on Friday it had found a new outbreak of African swine fever near the city of Lanzhou in northwestern Gansu province.
Categories: Health

Sun Pharma to test pancreatitis drug in COVID-19 patients in India

Health News (Reuters) - Fri, 05/29/2020 - 12:01
Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients.
Categories: Health

SoftBank leads $500 million fundraising for Didi's self-driving unit

Technology News (Reuters) - Fri, 05/29/2020 - 10:27
China's Didi Chuxing said on Friday it had completed a fundraising round of over $500 million for its autonomous driving subsidiary that was led by SoftBank Group's Vision Fund 2.
Categories: Technology

China says Canada is an accomplice of U.S. in Huawei case

Technology News (Reuters) - Fri, 05/29/2020 - 09:37
China's foreign ministry said on Friday that Canada is an accomplice to the U.S. government's efforts to bring down Chinese tech giant Huawei and said Canada should immediate release Huawei executive Meng Wanzhou.
Categories: Technology

Canada's Huawei extradition ruling could unleash more Chinese backlash

Technology News (Reuters) - Fri, 05/29/2020 - 09:37
A Canadian court ruling that could permit the extradition of a senior Huawei Technologies Co Ltd [HWT.UL] executive to the United States leaves Canada vulnerable to further retaliation from Beijing, analysts said.
Categories: Technology

Softbank-backed Coupang under scrutiny after S.Korea warehouse virus outbreak

Technology News (Reuters) - Fri, 05/29/2020 - 08:07
Deluged with online orders as the coronavirus epidemic swept South Korea, e-commerce giant Coupang opened a new groceries warehouse and logistics centre near Seoul in March, providing food and other essentials to shoppers sheltering at home.
Categories: Technology

Thailand reports 11 new coronavirus cases, no new deaths

Health News (Reuters) - Fri, 05/29/2020 - 06:12
Thailand confirmed 11 new coronavirus cases on Friday and no new deaths, taking the number of infections to 3,076.
Categories: Health

Germany's confirmed coronavirus cases rise by 741 to 180,458: RKI

Health News (Reuters) - Fri, 05/29/2020 - 04:35
The number of confirmed coronavirus cases in Germany increased by 741 to 180,458, data from the Robert Koch Institute (RKI) for infectious diseases showed on Friday.
Categories: Health

Trump move could scrap or weaken law that protects social media companies

Technology News (Reuters) - Fri, 05/29/2020 - 03:43
President Donald Trump said he will introduce legislation that may scrap or weaken a law that has protected internet companies, including Twitter and Facebook, in an extraordinary attempt to regulate social media platforms where he has been criticized.
Categories: Technology

U.S. FDA asks five firms to recall diabetes drug with high levels of probable carcinogen

Health News (Reuters) - Fri, 05/29/2020 - 02:47
The U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
Categories: Health
Syndicate content

eXTReMe Tracker